4//SEC Filing
MOEBIUS HANS 4
Accession 0001209191-22-004120
CIK 0001620463other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 5:25 PM ET
Size
7.9 KB
Accession
0001209191-22-004120
Insider Transaction Report
Form 4
MOEBIUS HANS
Chief Medical Officer
Transactions
- Award
Common Stock
2021-11-18$12.51/sh+829$10,371→ 31,256 total - Award
Stock Option (Right to Buy)
2022-01-18+180,000→ 180,000 totalExercise: $10.64Exp: 2032-01-17→ Common Stock (180,000 underlying)
Footnotes (4)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Athira Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of May 18, 2021 through November 18, 2021. This transaction is also exempt under Rule 16b-3(c).
- [F2]The Purchase Period ended November 18, 2021 and is the Purchase Period comprising the Offering Period (as defined in the ESPP) that began May 18, 2021.
- [F3]In accordance with the ESPP, these shares were purchased based on 85% of the closing price on November 18, 2021.
- [F4]One forty-eighth (1/48th) of the shares subject to the option will vest on February 18, 2022, and one forty-eighth of the shares subject to the option will vest each month thereafter.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001822494
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 5:25 PM ET
- Size
- 7.9 KB